The Community Guide

- gsearch

Search Results

Narrow Results:

2024 1
2021 1
2018 3
2017 1
2013 2
2012 1
2005 1

United States 1

Journal Article 5
Presentation 4

Conference Publications 4

1 - 10 of 10 Results

Refine Results

Refine Results:

Study of Healthcare Personnel with Influenza and other Respiratory Viruses in Israel (SHIRI): study protocol

CITE Title : Study of Healthcare Personnel with Influenza and other Respiratory Viruses in Israel (SHIRI): study protocol Personal Author(s) : Hirsch, Avital;Katz, Mark A.;Laufer Peretz, Alon;Greenberg, David;Wendlandt, Rachael;Shemer Avni, Yonat;Newes-Adeyi, Gabriella;Gofer, Ilan;Leventer-Roberts, Maya;Davidovitch, Nadav;Rosenthal, Anat;Gur-Arie, Rachel;Hertz, Tomer;Glatman-Freedman, Aharona;Monto, Arnold S.;Azziz-Baumgartner, Eduardo;Ferdinands, Jill Morris;Martin, Emily Toth;Malosh, Ryan E.;Neyra Quijandría, Joan Manuel;Levine, Min;Campbell, William;Balicer, Ran;Thompson, Mark G.; Corporate Authors(s) : on behalf of the SHIRI workgroup Published Date : November 06 2018 Source : BMC Infect Dis. 18 URL : https://stacks.cdc.gov/view/cdc/60733 Hirsch, Avital et al. (2018). Study of Healthcare Personnel with Influenza and other Respiratory Viruses in Israel (SHIRI): study protocol. 18 Hirsch, Avital et al. "Study of Healthcare Personnel with Influenza and other Respiratory Viruses in Israel (SHIRI): study protocol" 18 (2018) Hirsch, Avital et al. "Study of Healthcare Personnel with Influenza and other Respiratory Viruses in Israel (SHIRI): study protocol" vol. 18, 2018 Export RIS Citation Information.

:

Hirsch, Avital ;

Katz, Mark A.

November 06 2018 | BMC Infect Dis. 18

:

BackgroundThe Study of Healthcare Personnel with Influenza and other Respiratory Viruses in Israel (SHIRI) prospectively follows a cohort of healthcar...
Post–13-Valent Pneumococcal Conjugate Vaccine Dynamics in Young Children of Serotypes Included in Candidate Extended-Spectrum Conjugate Vaccines

CITE Title : Post–13-Valent Pneumococcal Conjugate Vaccine Dynamics in Young Children of Serotypes Included in Candidate Extended-Spectrum Conjugate Vaccines Personal Author(s) : Ben-Shimol, Shalom;Givon-Lavi, Noga;Kotler, Leore;Adriaan van der Beek, Bart;Greenberg, David;Dagan, Ron; Published Date : Jan 2021 Source : Emerg Infect Dis. 27(1):150-160 URL : https://stacks.cdc.gov/view/cdc/99974 Ben-Shimol, Shalom et al. (2021). Post–13-Valent Pneumococcal Conjugate Vaccine Dynamics in Young Children of Serotypes Included in Candidate Extended-Spectrum Conjugate Vaccines. 27(1). Ben-Shimol, Shalom et al. "Post–13-Valent Pneumococcal Conjugate Vaccine Dynamics in Young Children of Serotypes Included in Candidate Extended-Spectrum Conjugate Vaccines" 27, no. 1 (2021) Ben-Shimol, Shalom et al. "Post–13-Valent Pneumococcal Conjugate Vaccine Dynamics in Young Children of Serotypes Included in Candidate Extended-Spectrum Conjugate Vaccines" vol. 27, no. 1, 2021 Export RIS Citation Information.

:

Ben-Shimol, Shalom ;

Givon-Lavi, Noga

Jan 2021 | Emerg Infect Dis. 27(1):150-160

:

After worldwide implementation of 10-valent and 13-valent pneumococcal conjugate vaccines (PCV10/PCV13), a 20-valent PCV (PCV20) was developed. We ass...
Community Prescribing and Resistant Streptococcus pneumoniae

CITE Title : Community Prescribing and Resistant Streptococcus pneumoniae Personal Author(s) : Barkai, Galia;Greenberg, David;Givon-Lavi, Noga;Dreifuss, Eli;Vardy, Daniel;Dagan, Ron; Published Date : Jun 2005 Source : Emerg Infect Dis. 11(6):829-837. URL : https://stacks.cdc.gov/view/cdc/15855 Barkai, Galia et al. (2005). Community Prescribing and Resistant Streptococcus pneumoniae. 11(6). Barkai, Galia et al. "Community Prescribing and Resistant Streptococcus pneumoniae" 11, no. 6 (2005) Barkai, Galia et al. "Community Prescribing and Resistant Streptococcus pneumoniae" vol. 11, no. 6, 2005 Export RIS Citation Information.

:

Barkai, Galia ;

Greenberg, David

Jun 2005 | Emerg Infect Dis. 11(6):829-837.

:

We investigated the association between prescribing antimicrobial agents and antimicrobial resistance of Streptococcus pneumoniae among children with ...
Safety and immunogenicity in adults of revaccination with Adacel® vaccine 8-12 years after a previous dose

CITE Title : Safety and immunogenicity in adults of revaccination with Adacel® vaccine 8-12 years after a previous dose Personal Author(s) : Greenberg, David Corporate Authors(s) : Sanofi Pasteur. Conference Author(s) : United States. Advisory Committee on Immunization Practices. Meeting (2018 October 24 : Atlanta, GA) Published Date : October 25, 2018 Series : ACIP meeting Pertussis Vaccines URL : https://stacks.cdc.gov/view/cdc/61474 Greenberg, David (2018). Safety and immunogenicity in adults of revaccination with Adacel® vaccine 8-12 years after a previous dose. 201803(011203). Greenberg, David "Safety and immunogenicity in adults of revaccination with Adacel® vaccine 8-12 years after a previous dose" 201803, no. 011203 (2018) Greenberg, David "Safety and immunogenicity in adults of revaccination with Adacel® vaccine 8-12 years after a previous dose" vol. 201803, no. 011203, 2018 Export RIS Citation Information.

:

Greenberg, David

October 25, 2018 | ACIP meeting Pertussis Vaccines

:

Author's name from Agenda.
Fluzone® high-dose vaccine FIM12 efficacy trial summary results

CITE Title : Fluzone® high-dose vaccine FIM12 efficacy trial summary results Personal Author(s) : Greenberg, David Corporate Authors(s) : Sanofi Pasteur. Conference Author(s) : United States. Advisory Committee on Immunization Practices. Meeting (2013 October 23-24 : Atlanta, GA) Published Date : October 24, 2013 Series : ACIP meeting Influenza URL : https://stacks.cdc.gov/view/cdc/75348 Greenberg, David (2013). Fluzone® high-dose vaccine FIM12 efficacy trial summary results. 201303(020404). Greenberg, David "Fluzone® high-dose vaccine FIM12 efficacy trial summary results" 201303, no. 020404 (2013) Greenberg, David "Fluzone® high-dose vaccine FIM12 efficacy trial summary results" vol. 201303, no. 020404, 2013 Export RIS Citation Information.

:

Greenberg, David

October 24, 2013 | ACIP meeting Influenza

No Description
Fluzone® quadrivalent influenza virus vaccine in individuals 6 months and older

CITE Title : Fluzone® quadrivalent influenza virus vaccine in individuals 6 months and older Personal Author(s) : Greenberg, David Corporate Authors(s) : Sanofi Pasteur. Conference Author(s) : United States. Advisory Committee on Immunization Practices. Meeting (2012 October 24-25 : Atlanta, GA) Published Date : October 25, 2012 Series : ACIP meeting Influenza URL : https://stacks.cdc.gov/view/cdc/77942 Greenberg, David (2012). Fluzone® quadrivalent influenza virus vaccine in individuals 6 months and older. 201203(020608). Greenberg, David "Fluzone® quadrivalent influenza virus vaccine in individuals 6 months and older" 201203, no. 020608 (2012) Greenberg, David "Fluzone® quadrivalent influenza virus vaccine in individuals 6 months and older" vol. 201203, no. 020608, 2012 Export RIS Citation Information.

:

Greenberg, David

October 25, 2012 | ACIP meeting Influenza

:

08-influenza-greenberg.pdf
Yellow fever vaccine : update on implementation of IND protocol and vaccine distribution

CITE Title : Yellow fever vaccine : update on implementation of IND protocol and vaccine distribution Personal Author(s) : Greenberg, David Corporate Authors(s) : Sanofi Pasteur. Conference Author(s) : United States. Advisory Committee on Immunization Practices. Meeting (2017 June 21-22 : Atlanta, GA) Published Date : 7/19/2017 Pages in Document : 9 numbered slides Series : ACIP meeting Yellow Fever Vaccine URL : https://stacks.cdc.gov/view/cdc/58914 Greenberg, David (2017). Yellow fever vaccine : update on implementation of IND protocol and vaccine distribution. 201702(020202). Greenberg, David "Yellow fever vaccine : update on implementation of IND protocol and vaccine distribution" 201702, no. 020202 (2017) Greenberg, David "Yellow fever vaccine : update on implementation of IND protocol and vaccine distribution" vol. 201702, no. 020202, 2017 Export RIS Citation Information.

:

Greenberg, David

7/19/2017 | ACIP meeting Yellow Fever Vaccine

:

Presentations June 2017 Day 2yf-02-greenberg.pdf
Yellow fever vaccine : US supply update

CITE Title : Yellow fever vaccine : US supply update Personal Author(s) : Greenberg, David Corporate Authors(s) : Sanofi Pasteur. Conference Author(s) : United States. Advisory Committee on Immunization Practices. Meeting (2017 February 22-23 : Atlanta, GA) Published Date : 2018-03-20T15:40:38.9456Z Pages in Document : 11 numbered slides Series : ACIP meeting Yellow Fever Vaccine URL : https://stacks.cdc.gov/view/cdc/58818 Greenberg, David (2018). Yellow fever vaccine : US supply update. 201701(020602). Greenberg, David "Yellow fever vaccine : US supply update" 201701, no. 020602 (2018) Greenberg, David "Yellow fever vaccine : US supply update" vol. 201701, no. 020602, 2018 Export RIS Citation Information.

:

Greenberg, David

2018-03-20T15:40:38.9456Z | ACIP meeting Yellow Fever Vaccine

:

Presentations February 2017 Day 2On the agenda, this publication listed as: Update on yellow fever vaccine supply.yellow-fever-02-greenberg.pdf
Influence of Pneumococcal Vaccines and Respiratory Syncytial Virus on Alveolar Pneumonia, Israel

CITE Title : Influence of Pneumococcal Vaccines and Respiratory Syncytial Virus on Alveolar Pneumonia, Israel Personal Author(s) : Weinberger, Daniel M.;Givon-Lavi, Noga;Shemer-Avni, Yonat;Bar-Ziv, Jacob;Alonso, Wladimir J.;Greenberg, David;Dagan, Ron; Published Date : Jul 2013 Source : Emerg Infect Dis. 19(7):1084-1091. URL : https://stacks.cdc.gov/view/cdc/21615 Weinberger, Daniel M. et al. (2013). Influence of Pneumococcal Vaccines and Respiratory Syncytial Virus on Alveolar Pneumonia, Israel. 19(7). Weinberger, Daniel M. et al. "Influence of Pneumococcal Vaccines and Respiratory Syncytial Virus on Alveolar Pneumonia, Israel" 19, no. 7 (2013) Weinberger, Daniel M. et al. "Influence of Pneumococcal Vaccines and Respiratory Syncytial Virus on Alveolar Pneumonia, Israel" vol. 19, no. 7, 2013 Export RIS Citation Information.

:

Weinberger, Daniel M. ;

Givon-Lavi, Noga

Jul 2013 | Emerg Infect Dis. 19(7):1084-1091.

:

Postlicensure surveillance of pneumonia incidence can be used to estimate whether pneumococcal conjugate vaccines (PCVs) affect incidence. We used Poi...
Knowledge, attitudes, and practices associated with influenza vaccine uptake among healthcare personnel in Israel during three influenza seasons, 2016–2019☆

CITE Title : Knowledge, attitudes, and practices associated with influenza vaccine uptake among healthcare personnel in Israel during three influenza seasons, 2016–2019☆ Personal Author(s) : Yoo, Young M.;Katz, Mark A.;Greenberg, David;Marcenac, Perrine;Newes-Adeyi, Gabriella;Fowlkes, Ashley;Hirsch, Avital;Martin, Emily;Monto, Arnold;Thompson, Mark;Azziz-Baumgartner, Eduardo;Duca, Lindsey M.;Peretz, Alon; Published Date : 10 24 2024;10-24-; Source : Vaccine. 42(Suppl 4):126064 URL : https://stacks.cdc.gov/view/cdc/175242 Yoo, Young M. et al. (2024). Knowledge, attitudes, and practices associated with influenza vaccine uptake among healthcare personnel in Israel during three influenza seasons, 2016–2019☆. 42 Yoo, Young M. et al. "Knowledge, attitudes, and practices associated with influenza vaccine uptake among healthcare personnel in Israel during three influenza seasons, 2016–2019☆" 42 (2024) Yoo, Young M. et al. "Knowledge, attitudes, and practices associated with influenza vaccine uptake among healthcare personnel in Israel during three influenza seasons, 2016–2019☆" vol. 42, 2024 Export RIS Citation Information.

:

Yoo, Young M. ;

Katz, Mark A.

10 24 2024 | Vaccine. 42(Suppl 4):126064

:

Introduction:Despite a longstanding Israel Ministry of Health recommendation that all healthcare personnel (HCP) receive a seasonal influenza vaccine,...